GRAIL (STU:NL0) Dividend-Payout-to-FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:NL0 GRAIL Inc STU:NL0
11 GF Score
Price €93.06
! 2 Warning Signs
View Full Analysis

What is GRAIL Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.

STU:NL0
11GF Score
GRAIL Inc STU:NL0
Dividend-Payout-to-FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GRAIL Business Description

Other Exchanges GRAL:USANL0:Germany
Address 1525 O’Brien Drive, Menlo Park, CA, USA, 94025
GRAIL Inc. is a US healthcare company focused on early cancer detection through blood-based testing. Its flagship product, Galleri, is a multi-cancer early detection (MCED) test that analyzes cell-free DNA methylation patterns to identify signals associated with more than fifty cancer types, including many that lack recommended screening. GRAIL also offers targeted methylation-based research-use products and laboratory services. The company serves healthcare providers, health systems, employers, and life insurance partners, primarily in the United States, with additional availability in the United Kingdom through partnerships such as the NHS-Galleri trial. Revenue comes from sales of the Galleri test and related services, alongside research collaborations and pharmaceutical partnerships. GRAIL operates a single reportable segment and continues to pursue regulatory approvals and clinical validation to expand adoption of its MCED platform.
11GF Score

Get the complete analysis for STU:NL0

Dividend-Payout-to-FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€93.06
Price